Skip to main content
Lipocine Inc. logo

Lipocine Inc. — Investor Relations & Filings

Ticker · LPCN ISIN · US53630X1046 LEI · 549300RXPEQXOJXVBI10 US Manufacturing
Open in API
Filings indexed 788 across all filing types
Latest filing 2012-01-31 Regulatory Filings
Country US United States of America
Listing US LPCN

About Lipocine Inc.

https://www.lipocine.com/

Lipocine Inc. is a clinical-stage biopharmaceutical company that develops treatments for metabolic, endocrine, and central nervous system disorders. The company leverages its proprietary Lip'ral drug delivery technology to enhance the oral absorption of water-insoluble drugs, aiming to improve patient compliance and therapeutic outcomes. Its portfolio includes TLANDO®, an FDA-approved oral testosterone replacement therapy. Lipocine's development pipeline features candidates for conditions such as non-alcoholic steatohepatitis (NASH), postpartum depression, obesity, and prevention of preterm birth. The company's strategy often involves using the 505(b)(2) regulatory pathway to develop improved formulations of established drugs.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2012
Regulatory Filings
2012-01-31 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 95% confidence The document is a Form S-1/A Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the offering, company background, risk factors, use of proceeds, and financial statements. This type of filing is related to capital raising activities and is not an annual report, earnings release, or other types of filings. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement, not just an announcement or certification. Hence, the classification is CAP with high confidence.
2012-01-23 English
Regulatory Filings 2012
Regulatory Filings
2012-01-20 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is used by companies to register securities for public offering. The text includes detailed information about the offering, company background, risk factors, use of proceeds, and other disclosures typical of a registration statement prospectus. This is not a financial report, earnings release, or management discussion, but a capital raising filing. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, confirming it is not a mere announcement or certification.
2012-01-13 English
Regulatory Filings 2012
Regulatory Filings
2012-01-12 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is used by companies to register securities for public offering. The text includes detailed information about the offering, the company, use of proceeds, risk factors, and other disclosures typical of a registration statement prospectus. This is not an annual report, earnings release, or any other financial report type. It is a capital markets filing related to the company's initial or additional public offering of shares. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement amendment, not a brief announcement or certification, so it is not RNS or RPA.
2011-12-29 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.